Autopsy report · NCT02566109

Community Hospital Identification of High CV Risk Patients During Cancer Treatment

“Funding Issues”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year 7 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 1 year 6 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Wake Forest University Health Sciences

Sponsor type

University, hospital or other

Conditions

Breast Cancer

Interventions

Fast MRI

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Acetaminophen to Prevent Ischemic Oxidative Reperfusion Injury During Percutaneous Coronary Intervention for Acute Myocardial Infarction
  “Funding issue” (93% match in meaning)
• Biodentine Partial Pulpotomy of Pulpally Exposed Primary Molars
  “technical and funding issues” (85% match in meaning)
• Cannabinoids for Taxane Induced Peripheral Neuropathy
  “Funding being sought” (81% match in meaning)
• Pilot Study of the Sage Guard for Oral Cavity Protection
  “Funding constraints” (81% match in meaning)
• EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.
  “Inadequate funding” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.